Chemical Structure : TRI-611
CAS No.: 3117940-39-0
货号: PC-28067Not For Human Use, Lab Use Only.
TRI-611 is a potent, selective, CNS-penetrant molecular glue degrader of ALK, promotes the ubiquitination and degradation of ALK fusion alleles with clinically relevant acquired TKI resistance mutations.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥1780 | In stock | |
| 10 mg | ¥2780 | In stock | |
| 25 mg | ¥4980 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TRI-611 is a potent, selective, CNS-penetrant molecular glue degrader of ALK, promotes the ubiquitination and degradation of ALK fusion alleles with clinically relevant acquired TKI resistance mutations.
TRI-611 promotes tumor regression with daily oral dosing in both subcutaneous and intracranial models of ALK+ NSCLC.
TRI-611 shows broad selectivity across the global proteome including closely related kinases such as NTRK1, allowing for sustained high target coverage, including in the CNS, without the off-target liabilities that are associated with TKIs.
TRI-611 brings ALK and cereblon together through a unique binding mechanism that works independently of the kinase active site and harnesses the body’s innate protein-degradation machinery to selectively eliminate the ALK fusion protein.
| 分子量 | 404.38 | |
| 分子式 | C21H16N4O5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
3-(2-oxo-5-((3-phenyl-1,2,4-oxadiazol-5-yl)methyl)benzo[d]oxazol-3(2H)-yl)piperidine-2,6-dione |
|
1. Andrew R. Conery, et al. Mol Cancer Ther (2025) 24 (10_Supplement): B064.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright